Methods and compositions for treatment of bone defects with placental cell populations

Details for Australian Patent Application No. 2009283161 (hide)

Owner Anthrogenesis Corporation

Inventors Abramson, Sascha Dawn; Guelakis, Marian; Heidaran, Mohammad A.; Labazzo, Kristen; Yaccoby, Shmuel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009283161

PCT Pub. Number WO2010/021756

Priority 61/090,897 22.08.08 US; 61/090,898 22.08.08 US

Filing date 24 August 2009

Wipo publication date 25 February 2010

International Classifications

A61K 35/50 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/021756 Priority application(s): WO2010/021756

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009283162-Implantable medical device coatings with biodegradable elastomer and releasable taxane agent

2009283157-Formulation for oral administration of proteins